Clinical Trial Update: Milrinone Versus Dobutamine in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing milrinone to dobutamine in critically ill patients with low cardiac output syndrome or cardiogenic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Coronary Syndrome
• Low Cardiac Output Syndrome
• Pulmonary Edema

Drugs mentioned

• Dobutamine (dobutamine)
• Milrinone (milrinone)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Low Cardiac Output Syndrome, Cardiogenic Shock | Phase 4 | Status: COMPLETED